For over a decade, Pappas Ventures has been nurturing promising life sciences ideas and delivering superior results to investors and entrepreneurs alike.

Portfolio Highlights

• CeNeRx BioPharma initiates Phase 2 trial of its novel antidepressant agent Tyrima™
  October 17, 2008
• Anthera completes special protocol assessment with FDA and receives EMEA scientific advice regarding varespladib approval
  September 23, 2008
• CoLucid presents Phase 2 results of COL-144 at European Headache and Migraine Trust International Congress 2008
  September 5, 2008

Pappas Ventures News

• Arthur M. Pappas elected Board Chairman of North Carolina Biotechnology Center
  October 28, 2008
• Arthur Klausner to participate in the panel "Alternatives for Creating Value in a challenging time" at NASDAQ Healthcare Industry Forum in New York City
  December 8, 2008
• Art Pappas will participate on a panel called "Venture Capital and Private Equity - How Do You Look for the Next Big Investment" at the Drug Delivery Partnerships conference in Las Vegas
  January 22, 2009